image
Processa Pharmaceuticals, Inc. PCSA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.0099
-6.49 %
$ 3.3 M
Market Cap
-0.19
P/E
BALANCE SHEET
5.79 M ASSETS
-32.87%
Growth Rates
1Year -32.87%
3Years -38.78%
5Years -15.22%
7Years 191.48%
10Years 7.01%
797 K LIABILITIES
-30.60%
Growth Rates
1Year -30.60%
3Years -29.49%
5Years -25.66%
7Years -14.33%
10Years -4.53%
4.99 M EQUITY
-33.22%
Growth Rates
1Year -33.22%
3Years -39.86%
5Years -12.45%
7Years 22.43%
10Years 11.56%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Processa Pharmaceuticals, Inc.
image
Current Assets 5.63 M
Cash & Short-Term Investments 4.71 M
Receivables 0
Other Current Assets 926 K
Non-Current Assets 154 K
Long-Term Investments 0
PP&E 149 K
Other Non-Current Assets 5.54 K
Current Liabilities 731 K
Accounts Payable 312 K
Short-Term Debt 167 K
Other Current Liabilities 252 K
Non-Current Liabilities 66.9 K
Long-Term Debt 66.9 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
ASSETS
Cash & Cash Equivalents 4.7 6.5 16.5 15.4 0.7 1.7 2.8 3.24 K 2.09 K 21.2 K 0.2 1.0 2.8 0
Short Term Investments 0 0 0 0 0 0 0 1.0 0 0 0 0 0 0
Receivables 0 0 70.3 K 0.2 0 21.6 K 62.7 K 0 0 1.31 K 19.2 K 30.5 K 9.5 K 0
Inventory 0 0 0 0 0 0 0 0 0 0.2 0.2 48.7 K 0 0
Other Current Assets 0.9 3.8 1.8 0.6 0.6 0.3 41.4 K 0 0.1 0.2 0.2 50.4 K 0 0
Total Current Assets 5.6 8.4 18.3 16.2 1.0 2.0 3.0 3.24 K 0.1 0.4 0.5 1.2 2.8 0
PP&E 0.1 0.2 74.2 K 0.2 0.2 17.4 K 25.8 K 22.4 K 159 0.5 0.4 0.3 1.2 K 20 K
Intangible Assets 0 0 8.1 8.8 9.6 10.4 0 0 0 1.7 2.1 2.4 2.5 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 (2.1) (1.9) (1.1) 1.8 0 0 0 0 0 0 0 0
Other Long Term Assets 5.54 K 5.54 K 5.54 K 5.54 K 5.54 K (2.5) 5.54 K 5.53 K 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0.7 0 27.9 K 0 0 0 0 0 0
Total Assets 5.8 8.6 26.5 25.2 10.9 13.2 3.0 3.24 K 0.1 2.5 2.9 3.9 5.3 20 K
LIABILITIES
Accounts Payable 0.3 0.3 0.2 0.3 75.6 K 0.3 50.7 K 0.2 0.2 0.2 77 K 73.2 K 0 0
Short Term Debt 0.2 0.2 0.1 0.2 0.9 0.2 2.4 1.6 1.4 0.5 0.6 0.5 0.3 0
Other Current Liabilities 0.3 0.5 0.6 0.7 0.2 0.1 0.1 0.6 0.6 0.2 0.4 0.1 30.5 K 0
Total Current Liabilities 0.7 1.0 1.0 1.2 1.2 0.6 2.6 2.4 2.1 0.8 1.1 0.7 0.3 0
Long Term Debt 66.9 K 0.2 7.38 K 0.1 0.1 0 0 0 0 0.5 0.1 0.6 2.2 0
Deferred Tax Income 0 0 2.1 0.5 1.5 2.1 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0.4 0 0 9.96 K 0 0 0 0 0 0 0
Total Liabilities 0.8 1.1 1.0 2.3 2.9 3.5 2.6 2.4 2.1 1.3 1.3 1.3 2.5 0
EQUITY
Common Stock 129 1.61 K 1.57 K 1.42 K 549 3.87 K 3.53 K 1.1 K 1.1 K 1.1 K 808 190 280 0
Retained Earnings (75.4) (64.2) (36.8) (25.4) (11.0) (7.6) (3.9) (15.3) (14.9) (12.9) (6.8) (3.4) (0.9) 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0.003 (1.8) 3.25 K 19.2 K 19 K (0.2) 77.1 K 19.4 K 178 0
Total Equity 5.0 7.5 25.5 22.9 8.0 9.7 0.4 (2.4) (2.0) 1.2 1.7 2.6 2.8 20 K
Total Liabilities and Equity 5.8 8.6 26.5 25.2 10.9 13.2 3.0 3.24 K 0.1 2.5 2.9 3.9 5.3 20 K
SHARES OUTSTANDING
Common Shares Outstanding 1.3 0.8 0.8 0.4 0.3 0.3 0.2 11.2 K 11.2 K 9.04 K 5.14 K 4.09 K 8 K 8 K